1. Pozo M and Claret M. Hypothalamic Control of Systemic Glucose Homeostasis: The Pancreas Connection. Trends Endocrinol Metab 29, 581–594, 2018.
2. Ruud J, Steculorum SM, and Brüning JC. Neuronal control of peripheral insulin sensitivity and glucose metabolism. Nat Commun 8, 15259, 2017.
3. Hetherington AW and Ranson SW. The relation of various hypothalamic lesions to adiposity in the rat. J Comp Neurol 76, 475–499 ,1942.
4. Toda C, Kim JD, Impellizzeri D, Cuzzocrea S, Liu ZW, and Diano S. UCP2 Regulates Mitochondrial Fission and Ventromedial Nucleus Control of Glucose Responsiveness. Cell 164, 872–883, 2016.
5. Kunwar PS, Zelikowsky M, Remedios R, Cai H, Yilmaz M, Meister M, and Anderson DJ. Ventromedial hypothalamic neurons control a defensive emotion state. eLife 4, e06633, 2015.
6. Meek TH, Nelson JT, Matsen ME, Dorfman MD, Guyenet SJ, Damian V, Allison MB, Scarlett JM, Nguyen HT, Thaler JP, Olson DP, Myers MG Jr, Schwartz MW, and Morton GJ. Functional identification of a neurocircuit regulating blood glucose. PNAS 113, E2073–E2082 ,2016.
7. Coutinho EA, Okamoto S, Ishikawa AW, Yokota S, Wada N, Hirabayashi T, Saito K, Sato T, Takagi K, Wang CC, Kobayashi K, Ogawa Y, Shioda S, Yoshimura Y, and Minokoshi Y. Activation of SF1 Neurons in the Ventromedial Hypothalamus by DREADD Technology Increases Insulin Sensitivity in Peripheral Tissues. Diabetes 66, 2372–2386, 2017.
8. Sohn JW, Oh Y, Kim KW, Lee S, Williams KW, and Elmquist JK. Leptin and insulin engage specific PI3K subunits in hypothalamic SF1 neurons. Mol Metab 5, 669–679, 2016.
9. Klöckener T, Hess S, Belgardt BF, Paeger L, Verhagen LA, Husch A, Sohn JW, Hampel B, Dhillon H, Zigman JM, Lowell BB, Williams KW, Elmquist JK, Horvath TL, Kloppenburg P, and Brüning JC. High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons. Nat Neurosci 14, 911–918, 2011.
10. Roberts CK, Hevener AL, and Barnard RJ. Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training. Compr Physiol 3, 1–58, 2013.
11. Park HK and Ahima RS. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism 64, 24–34, 2015.
12. Minokoshi Y, Haque MS, and Shimazu T. Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes 48, 287– 291, 1999.
13. Toda C, Shiuchi T, Lee S, Yamato-Esaki M, Fujino Y, Suzuki A, Okamoto S, and Minokoshi Y. Distinct effects of leptin and a melanocortin receptor agonist injected into medial hypothalamic nuclei on glucose uptake in peripheral tissues. Diabetes 58, 2757– 2765, 2009.
14. Toda C, Shiuchi T, Kageyama H, Okamoto S, Coutinho EA, Sato T, Okamatsu-Ogura Y, Yokota S, Takagi K, Tang L, Saito K, Shioda S, and Minokoshi Y. Extracellular Signal– Regulated Kinase in the Ventromedial Hypothalamus Mediates Leptin-Induced Glucose Uptake in Red-Type Skeletal Muscle. Diabetes 62, 2295–2307, 2013.
15. Barsh GS and Schwartz MW. Genetic approaches to studying energy balance: perception and integration. Nat Rev Genet 3, 589–600, 2002.
16. Roh E and Kim MS. Brain Regulation of Energy Metabolism. Endocrinol Metab (Seoul) 31, 519–524, 2016.
17. Dodd GT, Michael NJ, Lee-Young RS, Mangiafico SP, Pryor JT, Munder AC, Simonds SE, Brüning JC, Zhang ZY, Cowley MA, Andrikopoulos S, Horvath TL, Spanswick D, and Tiganis T. Insulin regulates POMC neuronal plasticity to control glucose metabolism. eLife 7, e38704, 2018.
18. Könner AC, Janoschek R, Plum L, Jordan SD, Rother E, Ma X, Xu C, Enriori P, Hampel B, Barsh GS, Kahn CR, Cowley MA, Ashcroft FM, and Brüning JC. Insulin Action in AgRP-Expressing Neurons Is Required for Suppression of Hepatic Glucose Production. Cell Metab 5, 438–449, 2007.
19. Routh VH, Hao L, Santiago AM, Sheng Z, and Zhou C. Hypothalamic glucose sensing: making ends meet. Front Syst Neurosci 8, 2014.
20. Cai D and Khor S. “Hypothalamic Microinflammation” Paradigm in Aging and Metabolic Diseases. Cell Metab 30, 19–35, 2019.
21. Stoelzel CR, Zhang Y, and Cincotta AH. Circadian‐timed dopamine agonist treatment reverses high‐fat diet‐induced diabetogenic shift in ventromedial hypothalamic glucose sensing. Endocrinol Diab Metab 3, 2020.
22. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD, and Kuhajda FP. Reduced Food Intake and Body Weight in Mice Treated with Fatty Acid Synthase Inhibitors. Science 288, 2379–2381, 2000.
23. Pocai A, Obici S, Schwartz GJ, and Rossetti LA. brain-liver circuit regulates glucose homeostasis. Cell Metab 1, 53–61, 2005.
24. Bazinet RP and Layé S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci 15, 771–785, 2014.
25. Ghosh M, Tucker DE, Burchett SA, and Leslie CC. Properties of the Group IV phospholipase A2 family. Prog Lipid Res 45, 487–510, 2006.
26. Nonogaki K, Iguchi A, Yatomi A, Uemura K, Miura H, Tamagawa T, Ishiguro T, and Sakamoto N. Dissociation of hyperthermic and hyperglycemic effects of central prostaglandin F2α. Prostaglandins 41, 451–462, 1991.
27. Migrenne S, Cruciani-Guglielmacci C, Kang L, Wang R, Rouch C, Lefèvre AL, Ktorza A, Routh VH, Levin BE, and Magnan C. Fatty Acid Signaling in the Hypothalamus and the Neural Control of Insulin Secretion. Diabetes 55, S139–S144, 2006.
28. Obici S, Feng Z, Morgan K, Stein D, Karkanias G, and Rossetti L. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51, 271–275, 2002.
29. Kita H, Kochi S, Imai Y, Yamada A, and Yamaguchi T. Rigid external distraction using skeletal anchorage to cleft maxilla united with alveolar bone grafting. Cleft Palate Craniofac J 42, 318–327, 2005.
30. Yamada M, Kita Y, Kohira T, Yoshida K, Hamano F, Tokuoka SM, and Shimizu T. A comprehensive quantification method for eicosanoids and related compounds by using liquid chromatography/mass spectrometry with high speed continuous ionization polarity switching. J Chromatogr B 995–996, 74–84, 2015.
31. Ayala JE, Bracy DP, McGuinness OP, and Wasserman DH. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 55, 390–397, 2006.
32. Farooqui AA, Yang HC, Rosenberger TA, and Horrocks LA. Phospholipase A2 and Its Role in Brain Tissue. J Neurochem 69, 889–901, 1997.
33. Macedo F, dos Santos LS, Glezer I, and da Cunha FM. Brain Innate Immune Response in Diet-Induced Obesity as a Paradigm for Metabolic Influence on Inflammatory Signaling. Front Neurosci 13, 2019.
34. Posey KA, Clegg DJ, Printz RL, Byun J, Morton GJ, Vivekanandan-Giri A, Pennathur S, Baskin DG, Heinecke JW, Woods SC, Schwartz MW, and Niswender KD. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab 296, E1003–E1012, 2009.
35. Rapoport SI, Chang MC, and Spector AA. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J Lipid Res 42, 678–685, 2001.
36. Bruce KD, Zsombok A, and Eckel RH. Lipid Processing in the Brain: A Key Regulator of Systemic Metabolism. Front Endocrinol (Lausanne) 8, 2017.
37. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, and Davis RJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72, 269–278, 1993.
38. Jang Y, Kim M, and Hwang SW. Molecular mechanisms underlying the actions of arachidonic acid-derived prostaglandins on peripheral nociception. J Neuroinflammation 17, 2020.
39. Carboneau BA, Breyer RM, and Gannon M. Regulation of pancreatic β-cell function and mass dynamics by prostaglandin signaling. J Cell Commun Signal 11, 105–116, 2017.
40. He Y, Xu P, Wang C, Xia Y, Yu M, Yang Y, Yu K, Cai X, Qu N, Saito K, Wang J, Hyseni I, Robertson M, Piyarathna B, Gao M, Khan SA, Liu F, Chen R, Coarfa C, Zhao Z, Tong Q, Sun Z, and Xu Y. Estrogen receptor-α expressing neurons in the ventrolateral VMH regulate glucose balance. Nat Commun 11, 2020.
41. Parton LE, Ye CP, Coppari R, Enriori PJ, Choi B, Zhang CY, Xu C, Vianna CR, Balthasar N, Lee CE, Elmquist JK, Cowley MA, and Lowell BB. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 449, 228–232, 2007.
42. Shimazu T and Minokoshi Y. Systemic Glucoregulation by Glucose-Sensing Neurons in the Ventromedial Hypothalamic Nucleus (VMH). J Endocr Soc 1, 449–459, 2017.
43. Shimazu T, Sudo M, Minokoshi Y, and Takahashi A. Role of the hypothalamus in insulin-independent glucose uptake in peripheral tissues. Brain Res Bull 27, 501–504, 1991.
44. Sudo M, Minokoshi Y, and Shimazu T Ventromedial hypothalamic stimulation enhances peripheral glucose uptake in anesthetized rats. Am J Physiol.261, E298-303, 1991.
45. Kamohara S, Burcelin R, Halaas JL, Friedman JM, and Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389, 374–377, 1997.
46. Dhillon H, Zigman JM, Ye C, Lee CE, McGovern RA, Tang V, Kenny CD, Christiansen LM, White RD, Edelstein EA, Coppari R, Balthasar N, Cowley MA, Chua S Jr, Elmquist JK, and Lowell BB. Leptin Directly Activates SF1 Neurons in the VMH, and This Action by Leptin Is Required for Normal Body-Weight Homeostasis. Neuron 49, 191–203, 2006.
47. Irani, BG, Le Foll C, Dunn-Meynell A, and Levin BE. Effects of leptin on rat ventromedial hypothalamic neurons. Endocrinology 149, 5146–5154, 2008.
48. Zhang R, Dhillon H, Yin H, Yoshimura A, Lowell BB, Maratos-Flier E, and Flier JS. Selective Inactivation of Socs3 in SF1 Neurons Improves Glucose Homeostasis without Affecting Body Weight. Endocrinology 149, 5654–5661, 2008.
49. Buckman LB, Thompson MM, Moreno HN, and Ellacott KLJ. Regional astrogliosis in the mouse hypothalamus in response to obesity. J Comp Neurol 521, 1322–1333, 2013.
50. Palumbo S and Bosetti F. Alterations of brain eicosanoid synthetic pathway in multiple sclerosis and in animal models of demyelination: Role of cyclooxygenase-2. Prostaglandins, Leukot Essent Fat Acids 89, 273–278, 2013.
51. Berglund ED, Vianna CR, Donato J Jr, Kim MH, Chuang JC, Lee CE, Lauzon DA, Lin P, Brule LJ, Scott MM, Coppari R, and Elmquist JK. Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J Clin Invest 122, 1000–1009, 2012.
52. Bratusch-Marrain PR, Vierhapper H, Komjati M, and Waldhäusl WK. Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man. Diabetologia 28, 671–676, 1985.
53. Giugliano D, Sacca L, Scognamiglio G, Ungaro B, and Torella R. Influence of acetylsalicylic acid on glucose turnover in normal man. Diabete Metab 8, 279–282, 1982.
54. Newman WP and Brodows RG. Aspirin causes tissue insensitivity to insulin in normal man. J Clin Endocrinol Metab 57, 1102–1106, 1983.
55. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, and Shulman GI. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 109, 1321–1326, 2002.
論文の公開元へ
